INTRODUCTION
Despite its decreasing global incidence over the past few decades, gastric carcinoma remains one of the most common malignancies in many East Asian countries [1] . In Korea, gastric carcinoma is the most prevalent malignant neoplasm and continues to affect over 2,500 patients per year [2] . However, with widespread implementation of screening programs, early gastric cancer accounts for nearly 50% of all gastric cancers, and 5-year survival has reached up to 63 to 73% after curative resection [3] [4] [5] .
Given advances in the treatment techniques and the early thesurgery.or.kr diagnosis of gastric cancer, proper management of functional and nutritional impairments after gastric cancer surgery has also become a primary treatment concern in gastric cancer [6] .
Postsurgical anemia is frequently encountered during the early postoperative period after gastrectomy and may impair physical performance and postoperative recovery.
However, no standard care for postsurgical anemia, such as, concerning the use of iron or the best route for iron supplementation, has been established so far [7, 8] . In the studies regarding orthopedic or cardiac surgery, oral or intravenous iron supplementation showed little efficacy for postsurgical anemia [9] [10] [11] [12] . However, unlike patients undergoing orthopedic or cardiac surgery, patients with gastrectomy inevitably suffer from poor iron absorption from the gastrointestinal tract, and thus, this may adversely affect the physiologic recovery from postsurgical anemia [13] . Therefore, the use of iron supplementation for postsurgical anemia needs to be further evaluated in the subset of patients undergoing gastrectomy.
To facilitate proper management of postsurgical anemia, a comprehensive understanding about its clinical features is essential. Its prevalence, subsequent evolution, and the factors affecting the recovery should be taken into consideration when planning a treatment for postsurgical anemia. Therefore, we investigated clinical features of postsurgical anemia after gastrectomy, and sought to identify clinicopathological factors that affect its subsequent recovery.
METHODS

Patients
Between August 2008 and September 2009, 649 patients underwent curative surgery for gastric carcinoma at our institute. Of these patients, 198 patients that underwent preoperative or postoperative chemotherapy, 12 with combined resection of other organs, and 40 that experienced disease recurrence during the follow-up were excluded. Finally, 406 patients that received gastrectomy alone for the treatment of gastric carcinoma and followed for at least one year after surgery were enrolled in the present study. Patient data, such as, demographic characteristics, pathologic results, operative details, postoperative morbidity and mortality, and hospital courses were prospectively constructed using our electronic database recording system.
Postsurgical anemia was defined according to the World Health Organization definition based on hemoglobin (Hgb) value (Hgb ＜ 13 g/dL for males and ＜12 g/dL for females). The severity of anemia was also classified as mild (Hgb ≥ 10 g/dL), moderate (7 g/dL ≤ Hgb ＜ 10 g/dL), or severe (Hgb ＜ 7 g/dL) based on postoperative Hgb concentration [14] .
During the follow-up, all patients were monitored until 12 months post-surgery, with regular blood test on 3, 6, and 12 months post-surgery. No specific treatment was given to patients with postsurgical anemia. Instead, additional laboratory test for iron deficiency, including serum iron and ferritin and total iron biding capacity, was carried out when patients showed microcytic or hypochromic anemia on regular blood test from postoperative 3 months, and oral iron supplementation was indicated only for postsurgical anemia with an evidence of iron deficiency. Consequently, 11 patients received oral iron supplementation during the follow-up.
Operative procedures and perioperative care
Distal or total gastrectomy with regional lymph node dissection was performed in all patients. D2 lymph node dissection, as outlined by the Japanese Gastric Cancer Association, was the standard procedure used for advanced gastric cancer, and D1 plus beta lymph node dissection the standard procedure for early gastric cancer [15] . Laparoscopic surgery was indicated for patients with a preoperative diagnosis of cT1-2N0 gastric cancer.
Billroth I reconstruction was the primary procedure used after distal gastrectomy, and Billroth II or Roux-en Y gastrojejunostomy when gastroduodenostomy was not fea- SD, standard deviation; BMI, body mass index; TNM, tumornode-metastasis.
a)
The seventh edition of Union for International Cancer Control/ American Joint Committee on Cancer TNM classification. operative bowel preparation or nasogastric tube was used.
Patients were administered an oral diet from postoperative day 1, and intravenous fluid was restricted to 20 to 25 mL/kg/day during the first three postoperative days.
Prophylactic antibiotics were administered before skin incision and continued until 12 hours after surgery. Laboratory tests, such as, complete blood cell counts and blood chemistry, were regularly performed on postoperative days 1, 3, and 5. Transfusion was indicated for anemia with
Hgb concentration of ＜6 g/dL or active postoperative bleeding [16] . Hospital discharge was targeted for postoperative day 8, and objective discharge criteria were used to make decisions, that is, no sign of postoperative complications, the ability to ambulate without assistance, tolerable pain on oral analgesia, able to consume more than 70
per cent of meals, and a willingness to go home.
Statistical analysis
Continuous data were converted into means (standard deviations [SDs]) and analyzed using the Student's t-test.
The chi-square test was used to analyze categorical data.
When analyzing risk factors, continuous data were dichotomized into categorical data, which enables the chisquare test and logistic regression analysis to be used for univariate and multivariate analysis, respectively. All statistical analyses were performed using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA). P-values of ＜ 0.05 were regarded statistically significant.
RESULTS
Patient characteristics
The demographic and treatment characteristics of the 406 patients are summarized in 
Risk factors for developing postsurgical anemia
Of the 341 patients without preoperative anemia, 253
(74.2%) developed postsurgical anemia. Table 3 
Evolution of postsurgical anemia during follow-up
Factors affecting the recovery of postsurgical anemia
As we mentioned earlier, 11 postsurgical patients with iron deficiency received oral iron supplementation during the follow-up, and thus these patients were excluded from the analysis of factors affecting the recovery of postsurgical anemia to exclude the effects of iron treatment. (Table 5) . In the present study, old age, preoperative anemia, severity of anemia (moderate anemia), and total gastrectomy were found to be independent factors adversely affecting the recovery of postsurgical anemia. This is probably because elderly patients or patients that undergo total gastrectomy are more likely to suffer from iron malabsorption due to poor oral intake and malnutrition [18, 19] . Furthermore, patients with preoperative anemia possibly have underlying predisposition for the development of anemia. Therefore, our study suggests that the treatment of postsurgical anemia may require tailored approaches for these patients, such as an earlier active intervention or intravenous iron supplementation rather than oral supplementation. However, this also should be evaluated by clinical trials.
DISCUSSION
The treatment of postsurgical anemia, especially with respect to the efficacy of postoperative iron supplementation is an issue of long-standing debate [6, 7] . Inflammatory response after surgery reduces serum iron and transferrin and increases serum ferritin, which is indicative of a state of functional iron deficiency [20, 21] , and these physiologic changes may negate the effects of iron supplementation during the postoperative period. In fact, several studies have failed to identify a benefit of iron supplementation for the treatment of anemia after non-abdominal surgeries [9] [10] [11] [12] . However, unlike patients undergoing orthopedic or cardiac surgery, patients with gastrectomy inevitably suffer from poor iron absorption from the gastrointestinal tract, and thus, this may adversely affect the physiologic recovery from postsurgical anemia [22] . These arguments urge that the efficacy of iron supplementation during the treatment of postsurgical anemia and the optimal route of iron supplementation needs to be determined in patients undergoing gastrectomy.
It is well known that iron absorption is impaired in a multifactorial manner after gastrectomy, and reduced food intake, low gastric acidity, rapid gastric emptying, and bypass of the upper gastrointestinal tract have all been reported to contribute [22] . However, the extent and clinical consequences of iron malabsorption have not been fully investigated. In the present study, only six of 88 patients that did not develop postsurgical anemia developed anemia at 12 months postoperatively. This observation suggests that iron metabolism is relatively well conserved in normal patients despite gastrectomy. Turnberg [23] , in a experimental study of iron absorption in patient with gastrectomy, found that iron absorption was greater in a gastrectomy group than in a non-anemic control volunteer group. Kimber et al. [24] also concluded that iron malabsorption does not necessarily follow gastrectomy. Based on these previous studies and our results, we consider that the extent of iron malabsorption after gastrectomy is less likely to result in impaired hematopoiesis in normal patients, but that it has a serious impact on the physiological compensation required for recovery from postsurgical anemia.
Old age, lower BMI, and total gastrectomy were in- 
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